AMG 317

Generic Name: AMG 317
Study IDStudied Indication or DiseasePhaseStudy TitleSynopsis
20040183Asthma1A Randomized, Double-Blind, Placebo-Controlled, Single Rising Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 317 in Healthy Adults and in Adults with Mild to Moderate Persistent Asthma
20050163Asthma1A Randomized, Double-Blind, Placebo-Controlled, Rising Dose Study in Subjects with Mild to Moderate Asthma to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 317 after Multiple Dose Administration
20060161Chronic Asthma2A Randomized, Double-blind, Multiple Dose, Placebo-controlled Phase 2 Study to Determine the Safety and Efficacy of AMG 317 in Subjects With Moderate to Severe Asthma
20060242Asthma1bA Randomized, Double-Blind, Placebo-Controlled, Single Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of AMG 317 in Adolescent (= 12 to < 18 Years) and Adult Subjects with Intermittent or Mild to Moderate Persistent Asthma